NEO - NeoGenomics, Inc. Stock Analysis | ConvictionStocks
Healthcare
NeoGenomics, Inc.
NEO
$18.41+6.29%
Price is delayed.
Add to watchlist
About NeoGenomics, Inc.
NeoGenomics runs laboratories that test for cancer by analyzing blood and tissue samples. Hospitals, doctors, and pharmaceutical companies send them samples to identify what type of cancer a patient has and how to treat it. The company uses microscopes, DNA analysis, and other techniques to examine cells and chromosomes for signs of disease. They operate labs in the United States and the United Kingdom.
1D1W1M3M1Y5YMAX
Loading chart...
Chart powered by TradingView Lightweight Charts
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
What each number means, in plain English, with the Wall Street name where the two differ.
A plain-English summary of the company.
How many analysts cover it, and the count behind each rating.